{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:09:37Z","timestamp":1782821377468,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.thromres.2016.11.018","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T19:48:07Z","timestamp":1479757687000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Platelet function one and three months after coronary bypass surgery in relation to once or twice daily dosing of acetylsalicylic acid"],"prefix":"10.1016","volume":"149","author":[{"given":"Torbj\u00f6rn","family":"Ivert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Dal\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Ander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild","family":"St\u00e5lesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"N\u00e4sman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lordkipanidz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hjemdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.thromres.2016.11.018_bb0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0002-9149(74)90122-2","article-title":"Pathologic changes in aortocoronary saphenous vein grafts","volume":"34","author":"Unni","year":"1974","journal-title":"Am. J. Cardiol."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2016.11.018_bb0010","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0167-5273(97)00214-3","article-title":"Towards the prevention of vein graft failure","volume":"62","author":"Mehta","year":"1997","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.018_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198207083070201","article-title":"A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency","volume":"307","author":"Chesebro","year":"1982","journal-title":"N. Engl. J. Med."},{"issue":"8389","key":"10.1016\/j.thromres.2016.11.018_bb0020","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(84)92446-2","article-title":"Improved aortocoronary bypass patency by low-dose aspirin (100mg daily). Effects on platelet aggregation and thromboxane formation","volume":"1","author":"Lorenz","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.thromres.2016.11.018_bb0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.72.1.138","article-title":"Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery","volume":"72","author":"Brown","year":"1985","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2016.11.018_bb0030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.CIR.84.2.520","article-title":"Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group","volume":"84","author":"Goldman","year":"1991","journal-title":"Circulation"},{"issue":"6922","key":"10.1016\/j.thromres.2016.11.018_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bmj.308.6922.159","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2013II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration","volume":"308","year":"1994","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.thromres.2016.11.018_bb0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jtcvs.2007.11.033","article-title":"Detection and duration of aspirin resistance after coronary artery bypass grafting","volume":"135","author":"Zimmermann","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.018_bb0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jtcvs.2005.08.058","article-title":"Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting","volume":"131","author":"Poston","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2016.11.018_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.thromres.2004.07.004","article-title":"Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance","volume":"115","author":"Yilmaz","year":"2005","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.018_bb0055","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1160\/TH05-10-0653","article-title":"Dose- and time-dependent antiplatelet effects of aspirin","volume":"95","author":"Perneby","year":"2006","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.018_bb0060","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ahj.2012.06.008","article-title":"Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease","volume":"164","author":"Dillinger","year":"2012","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.018_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2010.02.025","article-title":"Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease","volume":"150","author":"Lordkipanidze","year":"2011","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.018_bb0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1160\/TH11-04-0216","article-title":"Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications","volume":"106","author":"Spectre","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.018_bb0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.110.960187","article-title":"Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease","volume":"4","author":"Capodanno","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"7","key":"10.1016\/j.thromres.2016.11.018_bb0080","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1538-7836.2012.04723.x","article-title":"The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes","volume":"10","author":"Rocca","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.018_bb0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/dme.12828","article-title":"Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with type 2 diabetes","volume":"33","author":"Bethel","year":"2016","journal-title":"Diabet. Med."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.018_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1160\/TH10-02-0082","article-title":"24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease","volume":"105","author":"Henry","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2016.11.018_bb0095","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2016.11.018_bb0100","series-title":"Position Paper on the Regulatory Requirements for the Authorisation of Low-dose Modified Release ASA Formulations in the Secondary Prevention of Cardiovascular Events","year":"2002"},{"key":"10.1016\/j.thromres.2016.11.018_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julious","year":"2005","journal-title":"Pharm. Stat."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.018_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/nur.20247","article-title":"Considerations in determining sample size for pilot studies","volume":"31","author":"Hertzog","year":"2008","journal-title":"Res. Nurs. Health"},{"issue":"4","key":"10.1016\/j.thromres.2016.11.018_bb0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ejcts\/ezs468","article-title":"EuroSCORE II and the art and science of risk modelling","volume":"43","author":"Nashef","year":"2013","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.018_bb0120","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-5223(94)70286-1","article-title":"Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization","volume":"108","author":"Hennein","year":"1994","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.018_bb0125","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1538-7836.2003.00109.x","article-title":"Biphasic pro-thrombotic and inflammatory responses after coronary artery bypass surgery","volume":"1","author":"Li","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"14","key":"10.1016\/j.thromres.2016.11.018_bb0130","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198304073081402","article-title":"Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients","volume":"308","author":"Weksler","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"37","key":"10.1016\/j.thromres.2016.11.018_bb0135","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"m. Authors\/Task Force","year":"2014","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.thromres.2016.11.018_bb0140","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"issue":"3\u20134","key":"10.1016\/j.thromres.2016.11.018_bb0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(80)90334-5","article-title":"Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo","volume":"18","author":"Cerskus","year":"1980","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.018_bb0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/jth.12832","article-title":"Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial","volume":"13","author":"Paikin","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2016.11.018_bb0155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pharmthera.2009.03.019","article-title":"Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence","volume":"123","author":"Lordkipanidze","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.018_bb0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00001721-199601000-00010","article-title":"Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment","volume":"7","author":"Beving","year":"1996","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.thromres.2016.11.018_bb0165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1097-0320(19990201)35:2<154::AID-CYTO7>3.0.CO;2-Y","article-title":"Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering","volume":"35","author":"Li","year":"1999","journal-title":"Cytometry"},{"issue":"33","key":"10.1016\/j.thromres.2016.11.018_bb0170","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.2174\/138161212803251952","article-title":"Platelet turnover in atherothrombotic disease","volume":"18","author":"Lordkipanidze","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"17","key":"10.1016\/j.thromres.2016.11.018_bb0175","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2016.11.018_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0049-3848(98)00126-1","article-title":"Influence of low- and high-dose aspirin treatment on thrombin generation in whole blood","volume":"92","author":"Wallen","year":"1998","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.thromres.2016.11.018_bb0185","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/jth.12728","article-title":"Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid","volume":"12","author":"Undas","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2016.11.018_bb0190","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1053\/euhj.1998.1088","article-title":"Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid","volume":"19","author":"Williams","year":"1998","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.thromres.2016.11.018_bb0195","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1172\/JCI116709","article-title":"Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins","volume":"92","author":"Valles","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.thromres.2016.11.018_bb0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816306302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T12:12:17Z","timestamp":1601208737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384816306302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":40,"alternative-id":["S0049384816306302"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet function one and three months after coronary bypass surgery in relation to once or twice daily dosing of acetylsalicylic acid","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2016.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}